Results 251 to 260 of about 3,969,245 (300)

Development of human monoclonal antibodies against TARM1 by yeast display

FEBS Open Bio, EarlyView.
Human monoclonal antibodies against TARM1 are generated by yeast display‐guided selection. These antibodies bind to soluble and cell‐surface forms of TARM1. Also, these antibodies exhibit agonistic activity in the NFAT‐GFP reporter assay, indicating that TARM1 signaling can be functionally modulated by antibodies and suggesting TARM1 as a potential ...
Rikio Yabe, Mayumi Saeki, Masaaki Hashiguchi, Sayaka Ono, Kazuhisa Aoki, Hidetaka Tanno   +5 more
wiley   +1 more source

NF-κB-Mediated Upregulation of Tissue Factor Contributes to the Procoagulant Phenotype of Smooth Muscle Cells from Abdominal Aorta Aneurysm in Human. [PDF]

Thromb Haemost
Regnault V, Didelot M, Ollivier V, Lakomy C, Lagrange J, Louis H, Denis CV, Malikov S, Lacolley P, Michel JB.   +9 more
europepmc   +1 more source

The impact of protein S and tissue factor pathway inhibitor on coagulation, assessed with thrombin generation, in women starting combined oral contraceptives. [PDF]

Res Pract Thromb Haemost
Strandberg J, Nybo J, Gade IL, Kristensen SR.   +3 more
europepmc   +1 more source

An Old Dog Performing the Same Old Tricks: The Role of TGF-β Receptor in Tissue Factor Release and Extracellular Vesicle Formation. [PDF]

Am J Respir Cell Mol Biol
Wade RC, Deshane JS.
europepmc   +1 more source

Elevated tissue factor pathway inhibitor delays thrombin generation in COVID-19 but is not associated with clinical outcomes. [PDF]

Blood Vessel Thromb Hemost
Eustes AS, Palani Kumar MK, Peterson JA, Mast AE, Lentz SR, Dayal S.   +5 more
europepmc   +1 more source

Tissue factor targeted near-infrared photoimmunotherapy: a versatile therapeutic approach for malignancies. [PDF]

Cancer Immunol Immunother
Takao S, Fukushima H, Furusawa A, Kato T, Okuyama S, Kano M, Yamamoto H, Suzuki M, Kano M, Choyke PL, Kobayashi H.   +10 more
europepmc   +1 more source

Tissue factor pathway inhibitor levels and atherothrombotic events in patients with chronic kidney disease or diabetes. [PDF]

J Thromb Thrombolysis
Brook R, Suleiman M, Rigano J, Lui B, Nandurkar H, Ho P, Lim HY.   +6 more
europepmc   +1 more source

Correction to "Systematic Study of Tissue Factor Expression in Solid tumors". [PDF]

Cancer Rep (Hoboken)
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Tissue Factor Signaling

Thrombosis and Haemostasis, 1999
Cell Biology of Tissue Factor Transmembrane receptor tissue factor (TF) initiates the coagulation pathways by serving as the cofactor for coagulation factor VIIa.1 The extracellular domain of TF consists of two fibronectin-type III modules in the orientation of a typical class II cytokine receptor extracellular domain,2 confirming the earlier ...
W, Ruf, B M, Mueller
openaire   +2 more sources

Tissue Factor on the Loose

Seminars in Thrombosis and Hemostasis, 2000
The enzymatic complex of tissue factor (TF) and the blood coagulation factor VIIa is generally considered to be the initiator of coagulation. Coagulation that occurs at the site of luminal injury to an artery is, along with platelet deposition, the cause of arterial thrombosis, which is the leading cause of death in Western society.
P L, Giesen, Y, Nemerson
openaire   +2 more sources